PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 1, 2010, Pages

  He, Quan ^a   Harding, Pamela ^a   LaPointe, Margot C ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Myocytes; Prostaglandin E; Prostaglandins; Receptor 4

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EARLY GROWTH RESPONSE FACTOR 1; G PROTEIN COUPLED RECEPTOR KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROTEIN C FOS; RAP PROTEIN; RAP1 PROTEIN; S6 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SIZE; GENE EXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL SIZE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; GENE EXPRESSION; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; RAP1 GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 73549086037     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00251.2009     Document Type: Article

References (76)

1. Ai J, Wang Y, Tan K, Deng Y, Luo N, Yuan W, Wang Z, Li Y, Wang Y, Mo X, Zhu C, Yin Z, Liu M, Wu X. A human homolog of mouse Lbh gene, hLBH, expresses in heart and activates SRE and AP-1 mediated MAPK signaling pathway. Mol Biol Rep 35: 179-187, 2008.
2. Bjorbaek C, Zhao Y, Moller DE. Divergent functional roles for p90rsk kinase domains. J Biol Chem 270: 18848-18852, 1995.
3. Blatteis CM, Li S, Li Z, Feleder C, Perlik V. Cytokines, PGE2 and endotoxic fever: a re-assessment. Prostaglandins Other Lipid Mediat 76: 1-18, 2005.
4. Bogoyevitch MA, Sugden PH. The role of protein kinases in adaptational growth of the heart. Int J Biochem Cell Biol 28: 1-12, 1996.
5. Bos JL. Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4: 733-738, 2003.
6. Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31: 680-686, 2006.
7. 1-Adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression. Endocrinology 137: 137-143, 1996.
8. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350, 2000.
9. Buitrago M, Lorenz K, Maass AH, Oberdorf-Maass S, Keller U, Schmitteckert EM, Ivashchenko Y, Lohse MJ, Engelhardt S. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 11: 837-844, 2005.
10. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S, Nemer M. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 15: 2702-2719, 2001.
11. Chen RH, Chung J, Blenis J. Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction. Mol Cell Biol 11: 1861-1867, 1991.
12. 2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cδ and Elk-1 signaling. Mol Cell Biol 26: 8281-8292, 2006.
13. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 273: 1496-1505, 1998.
14. de Rooij J, Rehmann H, van TM, Cool RH, Wittinghofer A, Bos JL. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275: 20829-20836, 2000.
15. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477, 1998.
16. 2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation 117: 1701-1710, 2008.
17. Desai S, April H, Nwaneshiudu C, Ashby B. Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol 58: 1279-1286, 2000.
18. 2: evidence for a vasodilator effect. J Appl Physiol 64: 728-741, 1988.
19. Ehses JA, Pelech SL, Pederson RA, McIntosh CH. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J Biol Chem 277: 37088-37097, 2002.
20. Freire G, Ocampo C, Ilbawi N, Griffin AJ, Gupta M. Overt expression of AP-1 reduces alpha myosin heavy chain expression and contributes to heart failure from chronic volume overload. J Mol Cell Cardiol 43: 465-478, 2007.
21. 2 activates Stat3 in neonatal rat ventricular cardiomyocytes: a role in cardiac hypertrophy. Cardiovasc Res 73: 57-65, 2007.
22. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151: 65-77, 1999.
23. 2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 278: 12151-12156, 2003.
24. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 159: 31-36, 1999.
25. Ghoda L, Lin X, Greene WC. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J Biol Chem 272: 21281-21288, 1997.
26. 1 muscarinic acetylcholine receptors to the activation of ERK1/2. J Biol Chem 276: 25568-25581, 2001.
27. He Q, Mendez M, LaPointe MC. Regulation of the human brain natriuretic peptide gene by GATA-4. Am J Physiol Endocrinol Metab 283: E50-E57, 2002.
28. 1- mediated response. J Biol Chem 265: 13809-13817, 1990.
29. Karliner JS, Simpson PC. β-Adrenoceptor and adenylate cyclase regulation in cardiac myocyte growth. Basic Res Cardiol 83: 655-663, 1988.
30. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 98: 186-191, 2006.
31. Kim SH, Yu HS, Park HG, Jeon WJ, Song JY, Kang UG, Ahn YM, Lee YH, Kim YS. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity. Prog Neuropsychopharmacol Biol Psychiatry 32: 1637-1642, 2008.
32. Kitamura T, Itoh M, Noda T, Tani K, Kobayashi M, Maruyama T, Kobayashi K, Ohuchida S, Sugimura T, Wakabayashi K. Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci 94: 618-621, 2003.
33. 2 synthesis and breast cancer growth. J Surg Res 63: 293-297, 1996.
34. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, Cohen RA, Liao R, Siwik DA, Colucci WS. α-Adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111: 1192-1198, 2005.
35. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides 26: 944-956, 2005.
36. LaPointe MC, Mendez M, Leung A, Tao Z, Yang XP. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 286: H1416-H1424, 2004.
37. LaPointe MC, Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor. Mol Endocrinol 7: 1284-1296, 1993.
38. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension 31: 218-224, 1998.
39. LaPointe MC, Wu G, Garami M, Yang XP, Gardner DG. Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension 27: 715-722, 1996.
40. + exchanger isoform 1. A role in ischemic neuronal death. J Biol Chem 282: 28274-28284, 2007.
41. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ. Role of c-Src tyrosine kinase in G protein-coupled receptor-and Gβγ subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443-19450, 1996.
42. Lyn D, Liu X, Bennett NA, Emmett NL. Gene expression profile in mouse myocardium after ischemia. Physiol Genomics 2: 93-100, 2000.
43. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 149: 1138-1141, 1994.
44. 2 in cardiac myocytes. Hypertension 39: 382-388, 2002.
45. 2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation. Am J Physiol Heart Circ Physiol 288: H2111-H2117, 2005.
46. Metrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E, Lezoualc'h F. Epac mediates β-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102: 959-965, 2008.
47. Meyer-Kirchrath J, Martin M, Schooss C, Jacoby C, Flogel U, Marzoll A, Fischer JW, Schrader J, Schror K, Hohlfeld T. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc Res 81: 310-318, 2009.
48. 2 induces hypertrophic changes and suppresses alpha-skeletal actin gene expression in rat cardiomyocytes. J Cardiovasc Pharmacol 50: 548-554, 2007.
49. Morel E, Marcantoni A, Gastineau M, Birkedal R, Rochais F, Garnier A, Lompre AM, Vandecasteele G, Lezoualc'h F. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 97: 1296-1304, 2005.
50. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
51. Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, Williams RS, Sukhatme VP, Vetter H. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hypertens 11: 927-934, 1993.
52. 2-mediated migration of first-trimester human extravillous trophoblast. Endocrinology 149: 1243-1251, 2008.
53. Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 117: 6085-6094, 2004.
54. 2-induced edema and hyperalgesia in rat paws: pharmacological data and biochemical correlates. J Gravit Physiol 11: 41-42, 2004.
55. Qian JY, Harding P, Liu Y, Shesely E, Yang XP, LaPointe MC. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction. Hypertension 51: 560-566, 2008.
56. 2 stimulates human brain natriuretic peptide expression via EP4 and p42/44 MAPK. Am J Physiol Heart Circ Physiol 290: H1740-H1746, 2006.
57. 2-synthesis and signalling in malignant transformation and progression. Mol Cancer 5: 62, 2006.
58. Saadane N, Alpert L, Chalifour LE. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am J Physiol Heart Circ Physiol 278: H796-H805, 2000.
59. Sadoshima J, Takahashi T, Jahn L, Izumo S. Roles of mechanosensitive ion channels, cytoskeleton, and contractile activity in stretch-induced immediate-early gene expression and hypertrophy of cardiac myocytes. Proc Natl Acad Sci USA 89: 9905-9909, 1992.
60. 2. Pflügers Arch 411: 121-125, 1988.
61. Sakai H, Urasawa K, Oyama N, Kaneta S, Saito T, Kitabatake A, Tsutsui H. Induction of c-fos mRNA expression by pure pressure overload in cultured cardiac myocytes. Int Heart J 48: 359-367, 2007.
62. Schmitt JM, Stork PJ. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 9: 85-94, 2002.
63. 2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153: 572-575, 1996.
64. Shamim A, Pelzer T, Grohe C, Neyses L. Induction of Egr-1 mRNA and protein by endothelin 1, angiotensin II and norepinephrine in neonatal cardiac myocytes. Mol Cell Biochem 195: 11-17, 1999.
65. Simpson PC, Long CS, Waspe LE, Henrich CJ, Ordahl CP. Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol 21, Suppl 5: 79-89, 1989.
66. Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 110: 13-30, 1987.
67. Starksen NF, Simpson PC, Bishopric N, Coughlin SR, Lee WM, Escobedo JA, Williams LT. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci USA 83: 8348-8350, 1986.
68. Sugden PH. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35: 871-886, 2003.
69. Takeishi Y, Abe J, Lee JD, Kawakatsu H, Walsh RA, Berk BC. Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. Circ Res 85: 1164-1172, 1999.
70. Takeishi Y, Huang Q, Abe J, Che W, Lee JD, Kawakatsu H, Hoit BD, Berk BC, Walsh RA. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res 53: 131-137, 2002.
71. Takeishi Y, Huang Q, Abe J, Glassman M, Che W, Lee JD, Kawakatsu H, Lawrence EG, Hoit BD, Berk BC, Walsh RA. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol 33: 1637-1648, 2001.
72. Tu VC, Bahl JJ, Chen QM. Distinct roles of p42/p44(ERK) and p38 MAPK in oxidant-induced AP-1 activation and cardiomyocyte hypertrophy. Cardiovasc Toxicol 3: 119-133, 2003.
73. 2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109: 2462-2468, 2004.
74. Yamazaki T, Komuro I, Yazaki Y. Molecular aspects of mechanical stress-induced cardiac hypertrophy. Mol Cell Biochem 163-164: 197-201, 1996.
75. Yang SH, Sharrocks AD, Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320: 3-21, 2003.
76. 2 and cyclic adenosine 3′-5′ monophosphate levels in the hypertrophied rat heart. Biol Res 25: 85-89, 1992.